Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Urinary bladder carcinoma is a significant health concern.
• Understanding the immune cell profile in cancer patients is crucial for prognosis and treatment.
• Previous studies have not fully elucidated the lymphocyte subset alterations in advanced bladder cancer.

Purpose of the Study:

• To investigate the complete lymphocyte profile in patients with advanced (T3) urinary bladder carcinoma.
• To compare immune cell percentages between cancer patients and healthy donors.
• To identify specific immune cell changes associated with bladder cancer.

Main Methods:

• Peripheral blood lymphocytes from 15 urinary bladder carcinoma patients and 10 healthy donors were analyzed.
• Monoclonal antibodies and indirect membrane immunofluorescence were used to quantify cell populations.
• Percentages of pan T (CD3+), T helper (CD4+), T cytotoxic/suppressor (CD8+), B (CD22+), and natural killer (CD57+) cells were estimated.

Main Results:

• A significant decrease in pan T (CD3+) lymphocytes was observed in cancer patients.
• A highly significant decrease in cytotoxic/suppressor T (CD8+) cells was found in urinary bladder cancer patients.
• An increased CD4/CD8 ratio and a higher frequency of natural killer (CD57+) cells were noted in patients compared to controls.

Conclusions:

• Advanced urinary bladder carcinoma is associated with a distinct alteration in peripheral blood lymphocyte populations.
• The decline in CD8+ lymphocytes and increase in CD57+ cells may play a role in disease progression.
• Further research is needed to understand the functional significance of these immune changes in bladder cancer.